{"nctId":"NCT01224236","briefTitle":"Randomized Trial of Iron Supplementation to Prevent Anemia in Very-low-birth-weight Infants","startDateStruct":{"date":"2010-07"},"conditions":["Anemia"],"count":150,"armGroups":[{"label":"iron supplementation","type":"EXPERIMENTAL","interventionNames":["Drug: Iron Supplement"]},{"label":"control","type":"SHAM_COMPARATOR","interventionNames":["Drug: control"]}],"interventions":[{"name":"Iron Supplement","otherNames":[]},{"name":"control","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. birth weight: \\< 1500 grams\n2. Tolerating iron fortified preterm formula or fortified breast milk at 120cc/kg/day by 8 weeks of age\n3. â‰¤32 weeks adjusted post-menstrual age at the time of enrollment\n\nExclusion Criteria:\n\n1. cyanotic heart disease\n2. bowel resection prior to enrollment","healthyVolunteers":false,"sex":"ALL","maximumAge":"8 Weeks","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Hematocrit (Hct)","description":"For infants discharged from the hospital before 36 weeks' postmenstrual age (PMA), the last Hct before discharge was used. For infants transferred before 36 weeks PMA, the Hct at 36 weeks was sought from the receiving hospital and used if available. For infants transferred before 36 weeks with no available Hct at 36 weeks, the last Hct before transfer was used. For those who died before 36 weeks PMA, the Hct at 36 weeks was considered to be missing.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29.2","spread":"4"},{"groupId":"OG001","value":"28.3","spread":"4.5"}]}]}]},{"type":"SECONDARY","title":"Transfusions","description":"\\# of transfusions infants required after enrollment.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":1,"n":76},"commonTop":[]}}}